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Availability of culture-free cognitive tests with marker properties for Alzheimer’s Disease (AD) has proved a barrier to global
harmonization strategies. The European Neurodegenerative Diseases Working Group suggested that the Short-Term Memory Binding Test (STMBT) and the Free
and Cued Selective Reminding Test (FCSRT) are useful tests for the early detection of AD (Costa et al., 2017). Yassuda et al. (2019) showed that STMB is insensitive
to age and education among healthy Brazilian adults. Parra et al. (2019) suggested that these tests should enter global strategies to aid the early detection of AD.
Evidence is still needed to ascertain that such a validity translates to the assessment of affected individuals from underrepresented populations. The current study
aimed to shed new light on such an outstanding question.
Background
Results The assessment confirmed the healthy (CDR=0.0,
pFAQ=2.2, BDI=5.9), MCI (CDR=0.5, pFAQ=3.7, BDI=6.2), and
dementia (CDR=1.3, pFAQ=16.5, BDI=7.2) status of our groups.
Methods
Discussion
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The two cognitive markers recently recommended for harmonisation of neuropsychological assessment in neurodegenerative dementias in
Europe seem suitable to support such practices in illiterate populations. Parra et al. (2019) recently suggested that only global strategies will help meet global
challenges. Here we provide evidence of cognitive markers for AD that can reliably enter such strategies.
We recruited 64 healthy controls (HC), 60 patients with Mild Cognitive
Impairment (MCI), and 63 patients with mild AD from [Lima at the regional area health clinics of
the “Dirección Regional de Salud (DIRESA)” of the “Gobierno Regional del Callao” between June
2018 and May 2019]. They were all illiterate. We considered Illiterate individuals who (1)
attended no school or were enrolled for less than one year and (2) could not read or write (a
booklet was given which showed a simple sentence). We assessed them with the STMBT, the
visual FCSRT, and a brief clinical-neuropsychological protocol.
Significant between-group differences were found with both the STMBT (F(2,184)=590.1, p<0.001)
and Free Recall during the visual FCSRT (F(2,184)=3936.2, p<0.001), with HC>>>MCI>>>AD.
ROC analysis with STMB
revealed AUC=0.98 for HC
vs. MCI, AUC=1.00 for HC
vs. AD, and AUC=0.97 for
MCI vs. AD. For the visual
FCSRT, an AUC=1.00 was
found for HC vs (MCI & AD),
and AUC=0.99 for MCI vs
AD.
Short-Term Memory Binding (STMB) Test: assesses the ability to temporarily retain
features such as shapes and colours integrated within object representations or
individually. The ability is assessed by detecting changes between two consecutive
displays, study and test.
ROC analysis revealed that for a cut-off value of 59.4%, the STMB test (Shape-
colour condition) achieved 100% sensitivity and 81% specificity to discriminate
between MCI and Controls. A cut-off value of 21 achieved 100% sensitivity and
specificity for the FCSRT. To discriminate between AD and Controls both tasks
achieved 100% sensitivity and specificity.
CDR: Clinical Dementia Rating Scale; PFAQ: Pfeffer Functional Activities Questionnaire; BDI_II:
Beck Depression Inventory.
